CREDIT SUISSE AG/ - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 162 filers reported holding KURA ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$655,655
-22.2%
71,892
-9.7%
0.00%0.0%
Q2 2023$842,274
-4.2%
79,610
+10.7%
0.00%0.0%
Q1 2023$879,386
+8.9%
71,904
+10.5%
0.00%0.0%
Q4 2022$807,245
+12.0%
65,048
+23.3%
0.00%0.0%
Q3 2022$721,000
-16.5%
52,759
+12.0%
0.00%0.0%
Q2 2022$863,000
+5.9%
47,098
-7.0%
0.00%0.0%
Q1 2022$815,000
+17.8%
50,650
+2.6%
0.00%
Q4 2021$692,000
-15.0%
49,383
+13.7%
0.00%
Q3 2021$814,000
-32.3%
43,445
-24.7%
0.00%
-100.0%
Q2 2021$1,203,000
+1.1%
57,727
+37.1%
0.00%0.0%
Q1 2021$1,190,000
-94.3%
42,102
-93.5%
0.00%
-90.0%
Q4 2020$21,004,000
+12.3%
643,124
+5.3%
0.01%
-9.1%
Q3 2020$18,707,000
+1726.9%
610,550
+872.4%
0.01%
+1000.0%
Q2 2020$1,024,000
+552.2%
62,788
+299.2%
0.00%
Q1 2020$157,000
-73.4%
15,729
-63.4%
0.00%
Q4 2019$591,000
+73.3%
43,012
+91.6%
0.00%
Q3 2019$341,000
-9.1%
22,453
+17.7%
0.00%
Q2 2019$375,000
+57.6%
19,082
+33.0%
0.00%
Q1 2019$238,000
+32.2%
14,351
+11.8%
0.00%
Q4 2018$180,000
-43.4%
12,833
-29.3%
0.00%
Q3 2018$318,000
+32.0%
18,142
+36.7%
0.00%
Q2 2018$241,000
+26.8%
13,273
+4.0%
0.00%
Q3 2017$190,00012,7610.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders